The European Innovation Council has announced that has completed a €5 million investment in Israeli Medical Start-up NanoVation. The equity investment comes after the €2.5 million grant already secured by the Haifa-based company last year from the EIC Accelerator.
Our Support to Cutting-Edge Innovations
Through a collaboration started three years ago, Alien Technology Transfer is proud to have helped NanoVation achieve this important milestone, becoming the first Israeli company to secure Bledend Finance (grant and equity investment) from the European Innovation Council.
The injection of funds will allow the Company to accelerate the final development and commercialization of SenseGuard, the Company’s innovative respiratory monitor for COPD patients based on proprietary first-of-a-kind nano-sensor technology.
A Vote of Confidence in the Team
NanoVation’s CEO, Dr Gregory Shuster, has declared: “We are grateful and honoured by the privilege of being the first Israeli company on such an exclusive list of companies, receiving both a grant and equity financing from the EIC. This is an additional endorsement of NanoVation and a vote of confidence in our team, in the novel technology we are developing, and in the significance of the problem we are addressing.”
You can read the full press release here.
Alien Technology Transfer is already supporting tens of innovative SMEs to navigate the new funding opportunities under Horizon Europe. If you are interested in innovation funding opportunities in Europe, please, contact us today.